Thermo Fisher Scientific Inc. closed 8.79% below its 52-week high of $627.88, which the company reached on September 10th.

Schneider Electric, today announced continued progress toward decarbonization for the pharmaceutical and healthcare sectors.

The deal was signed with the Energize programme, a renewable energy purchasing vehicle for pharmeceutical companies.

With U.S. President Donald Trump back in the White House, subsidies for ventures aimed at lowering emissions, championed by ...

EPS: US$16.58 (up from US$15.53 in FY 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue was in line with analyst estimates. Earnings per share (EPS) ...

ELIO, Thermo Fisher Scientific is closer to its goal of powering its European sites with 100% renewable energy ...

This marks the second round of layoffs at the company in less than three months. In November, the company cut 160 jobs across several Massachusetts sites, including the closure of its Lexington ...

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the international CorEvitas Adolescent Alopecia Areata (AA) Registry, addressing a critical unmet need ...

Bio-Techne beat second-quarter profit and revenue estimates on Wednesday, helped by growth in its protein sciences unit that makes products to develop therapies ...

Let's sort the S&P 500 healthcare sector again to show the 10 stocks with the highest percentages of "buy" or equivalent ratings. Only five companies are on both this list and the above growth list: ...

The global neurological biomarkers market is set to experience significant expansion in the coming years, driven by a growing demand for accurate diagnostic tools and advanced treatment monitoring ...